Carcinogenic chromium(VI)-induced protein oxidation and lipid peroxidation: Implications in DNA-protein crosslinking

Journal of Applied Toxicology

Volumn 28, Issue 8, 2008, Pages 987-997

  Mattagajasingh, Subhendra N ^a,c   Misra, Bhaba R ^b   Misra, Hara P ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Chromium; DNA protein crosslink; EPR; Lipid peroxidation; Malonaldehyde; Oxidative stress; Protein carbonyl; Protein oxidation

Indexed keywords

ALPHA TOCOPHEROL; AMITROLE; CARCINOGEN; CHROMIUM; GLUTATHIONE REDUCTASE; HYDROXYL RADICAL; MALONALDEHYDE; POTASSIUM CHROMATE; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RIBOFLAVIN; TIRON; WATER;

ARTICLE; CELL FREE SYSTEM; DOSE RESPONSE; ELECTRON SPIN RESONANCE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATION; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN CROSS LINKING; PROTEIN DNA BINDING; SPIN TRAPPING; T CELL LEUKEMIA;

1-OCTANOL; CARCINOGENS; CELL LINE, TUMOR; CHROMATES; CHROMIUM COMPOUNDS; CHROMIUM RADIOISOTOPES; CROSS-LINKING REAGENTS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; HYDROXYL RADICAL; LIPID PEROXIDATION; OXIDATION-REDUCTION; POTASSIUM COMPOUNDS; PROTEIN CARBONYLATION; PROTEINS; SOLVENTS;

EID: 55549094844     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1364     Document Type: Article

References (52)

1. Agency for Toxic Substances and Disease Registry. 1993. Toxicological profile for chromium. Report no. ATSDR/TP-92/08. Division of Toxicology/Toxicology Information Branch, Atlanta, GA.
2. Arreola-Mendoza L, Reyes JL, Melendez E, Martin D, Namorado MC, Sanchez E, Del Razo LM. 2006. Alpha-tocopherol protects against the renal damage caused by potassium dichromate. Toxicology 218: 237-246.
3. Biber TV, Mullen TL. 1977. Effect of inhibitors on transepithelial efflux of Na and nonelecrolytes in frog skin. Am. J. Physiol. 232: C67-C75.
4. Bose RN, Moghaddas S, Gelerinter E. 1992. Long-lived chromium(IV) and chromium(V) metabolites in the chromium(VI)-glutathione reaction: NMR, ESR, HPLC and kinetic characterization. Inorg. Chem. 31: 1987-1994.
5. Bosgelmez II, Guvendik G. 2004. Effects of taurine on oxidative stress parameters and chromium levels altered by acute hexavalent chromium exposure in mice kidney tissue. Biol. Trace Elem. Res. 102: 209-225.
6. Burton RM. 1957. The determination of glycerol and dihydroxyacetone. Meth. Enzymol. 3: 246-249.
7. Chaudhary AK, Nokubo M, Reddy RG, Yeola SN, Morrow JD, Blair IA, Marnett LJ. 1994. Detection of malonaldialdehyde-deoxyguanosine adducts in human liver. Science 265: 1580-1582.
8. Cohen MD, Latta DM, Coogan TP, Costa M. 1990. The reaction of metals with nucleic acids. In Biological Effect of Heavy Metals, vol. 2, Mechanism of Metal Carcinogenesis, Foulkes E (ed.). CRC Press: Boca Raton, FL; 19-77.
9. Cohen MD, Klein CB, Costa M. 1992. Forward mutations and DNA-protein crosslinks induced by ammonium metavanadate in cultured mammalian cells. Mutat. Res. 269: 141-148.
10. Coogan TP, Squibb KS, Motz J, Kinney PL, Costa M. 1991. Distribution of chromium within cells of the blood. Toxicol. Appl. Pharmac. 108: 157-166.
11. Costa M, Zhitkovich A, Toniolo P, Taiolo E, Popov T, Lukanova A. 1996a Monitoring human lymphocytic DNA-protein cross-links as biomarkers of active doses of chromate. Environ. Health Perspt. 104(suppl. 5): 917-919.
12. Costa M, Zitkovich A, Gargas M, Paustenbach D, Finley B, Kuykendall J, Billings R, Carlson TJ, Wetterhahn K, Xu J, Patierno S, Bogdanffy M. 1996b. Interlaboratory validation of a new assay for DNA-protein crosslinks. Mutat. Res. 369: 13-21.
13. Dizdaroglu M, Gajewski E. 1989. Structure and mechanism of hydroxyl radical-induced formation of a DNA-protein cross-link involving thymine and lysine in nucleohistone. Cancer Res. 49: 3463-3467.
14. Fatima S, Mahmood R. 2007. Vitamin C attenuates potassium dichromate-induced nephrotoxicity and alterations in renal brush border membrane enzymes and phosphate transport in rats. Lin. Chim. Acta 386: 94-99.
15. Fornace AJ Jr, Seres DS, Lechner JF, Harris CC. 1981. DNA-protein cross-linking by chromium salts. Chem.-Biol. Interact. 36: 345-354.
16. Fowler N, Gonzalez E, Rawlins FA, Giebisch GH, Whittembury G. 1977. Effect of hypertonic urea and mannitol on distal nephron permeability. Pflugers Arch. 368: 3-11.
17. Gajewski E, Dizdaroglu M. 1990. Hydroxyl radical induced cross-linking of cytosine and tyrosine in nucleohistone. Biochemistry 29: 977-980.
18. Goulart M, Batoreu MC, Rodrigues AS, Laires A, Rueff J. 2005. Lipoperoxidation products and thiol antioxidants in chromium exposed workers. Mutagenesis 20: 311-315.
19. IARC. 1990. Monograph on the evaluation of carcinogenic risk to humans. Chromium, Nickel and Welding, vol. 49. IARC: Lyon.
20. Jelmert O, Hansteen IL, Langard S. 1994. Chromosome damage in lymphocytes of stainless steel welders related to past and current exposure to manual metal arc welding fumes. Mutat. Res. 320: 23-233.
21. Jennette KW. 1962. Chromate metabolism in liver microsomes. Biol. Trace. Element Res. 1: 55-62.
22. Kalahasthi RB, Rao RH, Murphy RB, Kumar MK. 2006. Effect of chromium(VI) on the status of plasma lipid peroxidation and erythrocyte antioxidant enzymes in chromium plating workers. Chem. Biol. Interact. 164: 192-199.
23. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. 1990. Determination of carbonyl content in oxidatively modified proteins. Meth. Enzymol. 186: 464-478.
24. Love AHG. 2002. Chromium-biological and analytical considerations. In Chromium: Metabolism and Toxicity, Burrows D (ed.). CRC Press: Boca Raton, FL; 1-12.
25. Margolis SA, Coxon B, Gajewski E, Dizdaroglu M. 1988. Structure of a hydroxyl radical induced cross-link of thymine and tyrosine. Biochemistry 27: 6353-6359.
26. Mattagajasingh SN. 1995. Molecular mechanisms of the carcinogen chromium(VI)-induced DNA-protein crosslinking in cultured intact human cells. Ph.D. Dissertation, Virginia Tech, Blacksburgh, VA.
27. Mattagajasingh SN, Misra HP. 1995a. Alterations in the prooxidant and antioxidant status of human leukemic T-lymphocyte MOLT4 cells treated with potassium chromate. Mol. Cell. Biochem. 142: 61-70.
28. Mattagajasingh SN, Misra HP. 1995b. Modification of chromatin structure following exposure of MOLT4 cells to the carcinogenic chromium(VI). In Methods in Proteins Structure Analysis, Atassi MZ, Appella E (eds). Plenum Press: New York; 295-307.
29. Mattagajasingh SN, Misra HP. 1996. Mechanisms of the carcinogenic chromium(VI)-induced DNA-protein crosslinking and their characterization in cultured intact human cells. J. Biol. Chem. 271: 33550-33560.
30. Mattagajasingh SN, Misra HP. 1997. Carcinogenic chromium(VI) induces oxidative stress in cultured human leukemic T-lymphocytes. I. Generation of hydrogen peroxide during intracellular reduction of chromate. Toxic. Sub. Mech. 16: 63-79.
31. Mattagajasingh SN, Misra HP. 1999. Analysis of EDTA-chelatable proteins from DNA-protein crosslinks induced by a carcinogenic chromium(VI) in cultured intact human cells. Mol. Cell. Biochem. 199: 149-162.
32. Medeiros MG, Rodrigues AS, Batoreu MC, Laires A, Rueff J, Zhitkovich A. 2003. Elevated levels of DNA-protein crosslinks and micronuclei in peripheral lymphocytes of tannery workers exposed to trivalent chromium. Mutagenesis 18: 19-24.
33. Miller CA, III, Costa M. 1989. Analysis of proteins cross-linked to DNA after treatment of cells with formaldehyde, chromate, and cis-diamminedichloroplatinum(II). Mol. Toxicol. 2: 11-26.
34. Moghaddas S, Gelerinter E, Bose RN. 1995. Mechanism of formation and decomposition of hypervalent chromium metabolites in the glutathione- chromium(VI) reaction. J. Inorg. Biochem. 57: 135-146.
35. Ohkawa H, Ohishi N, Yagi K. 1979. Assays for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358.
36. Pinto J, Raiczyk GB, Huang, YP, Rivlin RS. 1986. New approaches to the possible prevention of side effects of chemotherapy by nutrition. Cancer 58: 1911-1914.
37. Rouzer CA, Chaudhary AK, Nokubo M, Ferguson DM, Reddy GR, Blair IA, Marnett LJ. 1997. Analysis of malondialdehyde-2′-deoxyguanosine adduct pyrimidopurinone in human leukocyte DNA by gas chromatography/electron capture/negative chemical ionization/mass spectroscopy. Chem. Res. Toxicol. 10: 8-88.
38. Salnikov K, Zhitkovich A, Costa M. 1992. Analysis of binding sites of chromium to DNA and protein in vitro and in intact cells. Carcinogenesis 13: 2341-2346.
39. Shi X, Dalal NS. 1989. Chromium(V) and hydroxyl radical formation during the glutathione-reductase catalyzed reduction of chromium(VI). Biochem. Biophys. Res. Commun. 163: 627-634.
40. Shi X, Dalal NS. 1990a. On the hydroxyl radical formation in the reaction between hydrogen peroxide and biologically generated chromium(V) species. Arch. Biochem. Biophys. 277: 342-350.
41. Shi X, Dalal NS. 1990b. Evidence for a Fenton-type mechanism for the generation of •OH radicals in the reduction of Cr(VI) in cellular media. Arch. Biochem. Biophys. 281: 90-95.
42. Stadtman ER, Oliver, CN. 1991. Metal-catalyzed oxidation of protein: physiological consequences. J. Biol. Chem. 266: 2005-2008.
43. Standeven AM, Wetterhahn KE. 1991. Is there a role of reactive oxygen species in the mechanism of chromium(VI) carcinogenesis? Chem. Res. Toxicol. 4: 616-625.
44. Sugiyama M. 1992. Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free. Radical. Biol. Med. 12: 397-407.
45. Summerfield F, Tappel A. 1984. Detection and measurement by high performance liquid chromatography of malondialdehyde complexes in DNA. Anal. Biochem. 143: 265-271.
46. Taioli E, Zhitkovich A, Kinney P, Udasin T, Toniolo P, Costa M. 1995. Increased DNA-protein crosslinks in lymphocytes of residents living in chromium-contaminated areas. Biol. Trace Elem. Res. 50: 175-180.
47. Travacio M, Polo JM, Llesug S. 2001. Chrmomium(VI)-induces oxidative stress in the mouse brain. Toxicology 162: 139-148.
48. Vaca CE, Fang J, Mutanen M, Valsta L. 1995. 32P-postlabelling determination of DNA adducts of MDA in humans: total white blood cells and breast tissue. Carcinogenesis 6: 847-885.
49. Voitkun V, Zhitkovich A. 1989. Analysis of DNA-protein crosslinking activity of malondialdehyde in vitro. Mutat. Res. 424: 97-106.
50. Wedrychowski A, Ward WS, Schmidt WN, Hnilica L. 1985. Chromium-induced crosslinking of nuclear proteins and DNA. J. Biol. Chem. 260: 7150-7155.
51. Zang LI, Misra HP. 1992. EPR kinetic studies of superoxide radicals generated during the autoxidation of 1-methyl-4-phenyl 2,3-dihydropyridinium, a bioactivated intermediate of parkinsonian-inducing neurotoxin 1-methyl-4-phenyl-4-1,2,3,6-tetrahydropyridine. J. Biol. Chem. 267: 23601-23608.
52. Zitkovich A, Costa M. 1992. A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo. Carcinogenesis 13: 1485-1489.